Gianni Chessari

Collaborator
DISC Type : si

Chief Scientific Officer at Astex Pharmaceuticals

Cambridge, England, United Kingdom

Overview

Gianni Chessari is the Chief Scientific Officer at Astex Pharmaceuticals, a company he joined in 2002. He has a distinguished track record in fragment-based and structure-based drug design, contributing significantly to the development of multiple small molecule drug candidates. He earned a PhD in Organic Chemistry from The University of Sheffield.

Gianni is passionate about translating scientific and technological innovation into new medicines for patients with cancer and other serious diseases. He is an advocate for fostering productive research collaborations with partners in both academia and the pharmaceutical industry, and supports a postdoctoral program to advance scientific talent.

He is a named inventor and author on more than 80 patents and publications, underscoring his extensive contributions to the field of drug discovery.

Personality Overview

Fair-minded

Appreciative

Consensus Builder

They are more likely to opt for solutions that are proven in the market.  Scenarios where both sides can come out as winners appeal to them greatly. Unlike D or C types, they are calm as well as friendly and can give the impression of being more receptive than they actually are.

Topics They Care About

Fragment-Based Discovery
He is a leading expert in Fragment-Based Drug Discovery (FBDD) and has been central to developing Astex's Pyramid™ platform and its extensive fragment library.
Tackling "Undruggable" Targets
Expresses excitement and inspiration for the challenge of drugging targets previously considered "undruggable" to create novel medicines for patients.
AI in Drug Discovery
He is leading initiatives to evolve Astex's platform by integrating cutting-edge AI, machine learning, and bioinformatics with experimental science.

Media Appearances

Gianni has no verified media appearances

Work History

9-2025
Chief Scientific Officer at Astex Pharmaceuticals
3-2024 - 9-2025
SVP, Head of Drug Discovery at Astex Pharmaceuticals
3-2023 - 3-2024
SVP, Head of Chemistry at Astex Pharmaceuticals
4-2020 - 3-2023
Vice President, Head of Medicinal Chemistry at Astex Pharmaceuticals
4-2019 - 3-2020
Senior Director, Head of Chemistry at Astex Pharmaceuticals

Education

1997 - 2000
PhD from The University of Sheffield

More Information

Social Presence :

Prographics :

Exp : 25 Location : Cambridge, England, United Kingdom Job Level : Leadership Designation : Chief Scientific Officer at Astex Pharmaceuticals
URL has been copied!

Insights For Selling To Gianni

During A Call Or A Meeting

DO's

  • Use phrases like ‘trust me when’, ‘your team will love’ etc.
  • If possible, involve their colleagues in the sales process
  • Show them how they look good by making this decision

DONT's

  • Don’t push them to make decisions very fast, let them take their time
  • Don’t sound very transactional
  • Don’t ask too many questions that sound too dry and objective

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Gianni is

  • Relationships can sway their decisions, followed by the low risk and the presence of good evidence.
  • Will you ever get a clear answer from Gianni

  • They are diplomatic when needed and rarely say no directly.

Insights For Deal Planning

    How fast (or slow) will Gianni move?

  • Even if they are engaged and friendly, they can take their time to make decisions.
  • Can Gianni take some risk or not?

  • They probably won’t put a lot at risk.

You And Gianni

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.